To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

September 26, 2019___

Today's Rundown

Featured Story

Enanta slides as midphase NASH data raise doubts about EDP-305

Shares in Enanta Pharmaceuticals fell 10% after the company posted phase 2a data on EDP-305 in nonalcoholic steatohepatitis patients. The trial narrowly hit its primary endpoint but tolerability concerns overshadowed the readout.

Top Stories

Jazz’s Xyrem follow-up flies through phase 3, poised for 2020 launch

Jazz Pharmaceuticals’ narcolepsy drug bested placebo at keeping patients awake during the day and tamping down on cataplexy attacks, or sudden and uncontrollable muscle weakness or paralysis that affects people with narcolepsy during the day.

Meissa raises $30M to take RSV vaccine into the clinic

Meissa Vaccines has raised $30 million to advance a pipeline of vaccines to prevent viral respiratory infections. The series A equips Meissa to run phase 1 and 2 trials of a respiratory syncytial virus vaccine.

Moderna pens mRNA immunotherapy pact with Harvard

Buzzy biotech Moderna is to use its mRNA tech to “explore fundamental immunological processes” with researchers at Harvard in a collab effort aimed at seeking out new meds.

20-year GSK veteran takes up CSO role at metabolic startup HemoShear

After spending more than two decades at GlaxoSmithKline and helping develop one of the most widely used HIV drugs in the world, Brian Johns, Ph.D., is stepping into the biotech world.

CAR-T with a new target could address cancer relapses

City of Hope researchers have developed a new CAR-T that targets B cell-activating factor receptor (BAFF-R). Animal studies suggest it could be used to treat patients who relapse after receiving immunotherapy treatments that target CD19.

Synteract nabs CRO, pharma veterans to bolster cancer and rare disease offerings

After a mini M&A spree and new hires last year, CRO Synteract is looking to boost its work again, this time by hiring two life science stalwarts into its ranks.

Enrollment Showcase

BioImmersion: Biotech for the Non-Scientist

BioImmersion: Biotech for the Non-Scientist is a three-day, in-depth course that delves into the scientific details on a broad number of biotechnology topics. Register today!

Resources

[Whitepaper] Webinar Benchmarks Report for Life Sciences 2019

Compare digital program performance and audience engagement among your life sciences peers.

[Webinar] Clinically Integrated Networks: A Growing Disruptor in American Healthcare

Clinically Integrated Networks are vehicles for powerful IDNs to extend their influence into the physician sector and play a key role for IDNs trying to pave a path to becoming a self-contained healthcare ecosystem.

[Whitepaper] Advanced Analytical Approaches for Accelerated Development of Gene Therapy Products

Download the White Paper and learn how detailed characterization can guide successful development of gene therapy products.

[Whitepaper] Fail Fast. Succeed Faster.

Slashing your R&D costs is easier than you think.

[Whitepaper] Innovative Funding Models for Treatment of Cancer and Other High-Cost Chronic Noncommunicable Diseases

A global landscape study of funding trends and innovations.

[Whitepaper] Understanding Precision Medicine in Oncology

White paper providing an overview of precision medicine in oncology, as well as a look ahead at future developments and keys to success for pharmaceutical and diagnostics companies.

[Whitepaper] How Can You Avoid the Fallout From Incompatibility Between Your API and Its Formulation?

Avoid potential risks to the patient as well as costly interruptions during development.

[Article] Why Market Leaders Outsource IT Requirements For A Competitive Edge

Find out how outsourcing your IT requirements enhances the bottom line while creating strategic advantage.

[Whitepaper] From Complex to Controlled: Advanced Data Management Strategies for Advanced Therapies

Developing a cell therapy, gene therapy, or personalized cancer vaccine? Modern data management makes a critical difference in operational and regulatory outcomes. This whitepaper will help your team leverage the latest data strategies for success.

[Whitepaper] Advancing Healthcare Market Intelligence With Smart Search Technology

AI-powered research tools are making it easier to source confident healthcare market intelligence with accuracy and efficiency -- download now to learn more about improving your competitive research strategy.

[Whitepaper] What's Your Lab Trying to Tell You? Listen with Connected IoT Sensors

Your lab is talking to you, are you listening?

[Whitepaper] Prevent the Real World From Derailing Your Clinical Trial: Focus on Protocol Design

Want to be sure your renal research protocol design is fit for the real world?

[Whitepaper] Optimizing Operations in Multiproduct Pharma Manufacturing Facilities

Vetting CDMOs but unsure what to look for in prospective partners’ multiproduct facilities?

[Report] Future of clinical trials: From real-time data to algorithmic trials

Clinical trials are one of the pharma industry’s most painful and costly processes. Read how technology could transform the trial process from nine years to a matter of hours.

[Whitepaper] Considerations and Options for Prefilled Syringes

Check out Baxter BioPharma Solutions’ whitepaper to learn considerations and options for developing a product in a prefilled syringe.

[Case Study] Clinical Supply Management

Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study.

[Video] Demand Led Services and Clinical Supply Efficiency

Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels.

[eBook] Strategies for Efficient Clinical Supply Management and Forecasting

Download the eBook to explore a proactive approach for clinical supply management.

Events